Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva

Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnosti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reiko Tokuyama-Toda, Masaaki Muraoka, Chika Terada-Ito, Shinji Ide, Toshikatsu Horiuchi, Tsuyoshi Amemiya, Airi Fukuoka, Yoshiki Hamada, Shunsuke Sejima, Kazuhito Satomura
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7f339b6d00b749bbb45923d23235e97b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f339b6d00b749bbb45923d23235e97b
record_format dspace
spelling oai:doaj.org-article:7f339b6d00b749bbb45923d23235e97b2021-11-25T17:20:52ZFeasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva10.3390/diagnostics111120242075-4418https://doaj.org/article/7f339b6d00b749bbb45923d23235e97b2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2024https://doaj.org/toc/2075-4418Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnostic method for SARS-CoV-2. First, we examined whether anyone could easily operate this device. Then, we examined whether RNA in the mouthwash could be detected in a short time. In addition, we investigated whether it was possible to diagnose SARS-CoV-2 infection using mouthwash obtained from COVID-19 patients undergoing hospitalization. The results revealed that all subjects were able to complete the operation properly without error. In addition, RNase P was detected in the mouthwash without pretreatment. The average detection time was 18 min, which is significantly shorter than conventional qPCR devices. Furthermore, this device detected SARS-CoV-2 in the mouthwash of a COVID-19 patient undergoing hospitalization. The above findings verified the efficacy of this diagnostic method, which had a low risk of infection, was technically simple, and provided stable results. Therefore, this method is useful for the rapid detection of SARS-CoV-2.Reiko Tokuyama-TodaMasaaki MuraokaChika Terada-ItoShinji IdeToshikatsu HoriuchiTsuyoshi AmemiyaAiri FukuokaYoshiki HamadaShunsuke SejimaKazuhito SatomuraMDPI AGarticleCOVID-19SARS-CoV-2mobile qPCR devicemouthwashsalivaMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2024, p 2024 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
mobile qPCR device
mouthwash
saliva
Medicine (General)
R5-920
spellingShingle COVID-19
SARS-CoV-2
mobile qPCR device
mouthwash
saliva
Medicine (General)
R5-920
Reiko Tokuyama-Toda
Masaaki Muraoka
Chika Terada-Ito
Shinji Ide
Toshikatsu Horiuchi
Tsuyoshi Amemiya
Airi Fukuoka
Yoshiki Hamada
Shunsuke Sejima
Kazuhito Satomura
Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
description Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnostic method for SARS-CoV-2. First, we examined whether anyone could easily operate this device. Then, we examined whether RNA in the mouthwash could be detected in a short time. In addition, we investigated whether it was possible to diagnose SARS-CoV-2 infection using mouthwash obtained from COVID-19 patients undergoing hospitalization. The results revealed that all subjects were able to complete the operation properly without error. In addition, RNase P was detected in the mouthwash without pretreatment. The average detection time was 18 min, which is significantly shorter than conventional qPCR devices. Furthermore, this device detected SARS-CoV-2 in the mouthwash of a COVID-19 patient undergoing hospitalization. The above findings verified the efficacy of this diagnostic method, which had a low risk of infection, was technically simple, and provided stable results. Therefore, this method is useful for the rapid detection of SARS-CoV-2.
format article
author Reiko Tokuyama-Toda
Masaaki Muraoka
Chika Terada-Ito
Shinji Ide
Toshikatsu Horiuchi
Tsuyoshi Amemiya
Airi Fukuoka
Yoshiki Hamada
Shunsuke Sejima
Kazuhito Satomura
author_facet Reiko Tokuyama-Toda
Masaaki Muraoka
Chika Terada-Ito
Shinji Ide
Toshikatsu Horiuchi
Tsuyoshi Amemiya
Airi Fukuoka
Yoshiki Hamada
Shunsuke Sejima
Kazuhito Satomura
author_sort Reiko Tokuyama-Toda
title Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_short Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_full Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_fullStr Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_full_unstemmed Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_sort feasibility of rapid diagnostic technology for sars-cov-2 virus using a trace amount of saliva
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/7f339b6d00b749bbb45923d23235e97b
work_keys_str_mv AT reikotokuyamatoda feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT masaakimuraoka feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT chikateradaito feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT shinjiide feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT toshikatsuhoriuchi feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT tsuyoshiamemiya feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT airifukuoka feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT yoshikihamada feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT shunsukesejima feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT kazuhitosatomura feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
_version_ 1718412480073433088